Policy support: Amino acid series products are listed as encouraged development projects by the National Development and Reform Commission. According to the National Development and Reform Commission Order 40 "Industrial Structure Adjustment Guidance Catalogue", this project belongs to construction projects that comply with national laws and regulations and related policies allow. It is listed as a high-tech export product in the "National High-tech Export Product Catalog" issued by the five ministries and commissions of the Ministry of Science and Technology, the Ministry of Foreign Trade and Economic Cooperation, the General Administration of Customs, the State Administration of Taxation, and the Ministry of Finance.
Industry prospects: In recent years, the international pharmaceutical, food, feed and other industries have developed rapidly, and the demand for amino acids has been increasing. Amino acid series products have a broad market and are currently mainly used for export. They are sold to Japan, the United States, Germany, France, Spain, Taiwan, South Korea and other countries and regions. Every year China's demand for amino acid series products is constantly increasing. As long as humans and animals exist, there is a demand for amino acids, so people say that amino acids are sunrise products. This product has become one of the important fine chemical export varieties in China. According to statistics, China's total output of medicinal amino acids alone has exceeded 4,000 tons, a net increase of eight times over the 1980s. A market research report titled "The Protein Therapeutics Market: The Science and Business of a Growing Sector" states that due to the current 80% of the global protein drug market sales Driven by strong demand and sales in the US and European markets, the protein drug market in 2010 may reach $ 87 billion in sales. Obviously, this provides an opportunity for the development of the amino acid market. In addition, driven by the growing strength of biopharmaceutical technology in recent years, the market supply and demand and industrial strength of amino acids will also keep up. According to a research reported by McKinsey Management Consulting, except for the pharmaceutical distribution industry in 2009, all sub-sectors will maintain a high growth rate. The biological products industry is particularly prominent, with a growth rate of 27%, and favorable policies are expected to enhance its long-term growth capacity. Biological products have the most growth prospects.
The biological products industry has technological and performance advantages over the remaining sub-industries. China's biological products industry is at an early stage of growth and has maintained rapid growth over the years.
